Performance of Afirma genomic sequencing classifier and histopathological outcome are associated with patterns of atypia in Bethesda category III thyroid nodules

BACKGROUND: Data on Afirma’s genomic sequencing classifier (GSC) performance in atypia of undetermined significance (AUS) subcategories is limited. This study investigated GSC performance in AUS nodules with architectural atypia (AUS‐A), cytological atypia (AUS‐C), architectural and cytological atyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Xiaobing, Lew, Madelyn, Pantanowitz, Liron, Smola, Brian, Jing, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796557/
https://www.ncbi.nlm.nih.gov/pubmed/35789120
http://dx.doi.org/10.1002/cncy.22625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796557/
https://www.ncbi.nlm.nih.gov/pubmed/35789120
http://dx.doi.org/10.1002/cncy.22625

Ejemplares similares